Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant

Clinical trial NCT04239989 · TERMINATED

Trial details

NCT number: NCT04239989
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Bronchiolitis Obliterans

Start date: 2021-10-08
Primary completion: 2025-10-31
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.